Delivery Order SPE2DB22D3501-SPE2DB25FUL96

Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The award, valued at $6,502.20, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,075.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025,...
This federal contract award is for Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver epinephrine 0.3 mg auto-injector to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,593.12 and is a firm fixed price delivery order that will run through October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under a Delivery Order valued at $3,705.14. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The award, valued at $4,251.44, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company that holds multiple federal contracts. The contract has a firm fixed-price delivery order structure and an ultimate completion date of May 24, 2024. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract...
The federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The fixed-price, firm-fixed delivery order, valued at $1,861.44, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
The federal contract award is for the delivery of EPINEPHRINE 0.15 MG AUTO-INJCT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,209.03 fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of July 31, 2024 and is not set aside. As a significant Indefinite Delivery Contract (IDC) holder with the DLA...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA). The $1,794.36 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,351.56, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 14, 2023. The contract is not designated with a set-aside requirement,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUL96
    Delivery Order

This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $2,766.96. This is a Firm Fixed Price delivery order contract with a completion date of February 7, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contract vehicles enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/8/25, 9:49 AM